| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/14/1993 | EP0550629A1 Metal ion mediated receptor binding of polypeptide hormones |
| 07/14/1993 | EP0550626A1 Method of improving the yield of heterologous proteins produced by streptomyces lividans |
| 07/14/1993 | EP0550625A1 Bmp-5 derivatives |
| 07/14/1993 | EP0550599A1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
| 07/14/1993 | EP0550561A1 Purification of cytokeratin fragments |
| 07/14/1993 | EP0550558A1 Acellular vaccine |
| 07/14/1993 | EP0550553A1 Viral defective vaccine produced by transcomplementing cell line |
| 07/14/1993 | EP0550528A1 Active site of interleukin-8: polypeptide analogs and antibodies |
| 07/14/1993 | EP0550519A1 Nucleotide sequences coding for a human protein with angiogenesis regulative properties |
| 07/14/1993 | EP0550506A1 Novel chemotactic factor |
| 07/14/1993 | EP0550500A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF PROTEIN MTP40 OF $i(M. TUBERCULOSIS) AND SYNTHETIC PEPTIDES DERIVED THEREFROM |
| 07/14/1993 | EP0550485A1 DERIVATIVES OF gp160 AND VACCINES BASED ON gp160 OR A DERIVATIVE THEREOF, CONTAINING AN ADJUVANT |
| 07/14/1993 | EP0550479A1 Poly(fluoroalkyl) sugar reagents and their use for surface modification |
| 07/14/1993 | EP0550465A1 Entamoeba histolytica immunodominant surface antigens |
| 07/14/1993 | EP0550453A1 Interleukin-2-leukotoxin gene fusions and uses thereof |
| 07/14/1993 | EP0550428A1 Promoter probe vectors, able to replicate in e.coli, b.subtilis, lactococci and lactobacillus as well as uses thereof |
| 07/14/1993 | EP0497928A4 Yeast-derived epidermal growth factor/urogastrone-like products |
| 07/14/1993 | EP0472712A4 Novel sequences preferentially expressed in early seed development and methods related thereto |
| 07/14/1993 | CN1074220A Cell-free ciliary neurotrophic factor/receptor complex |
| 07/14/1993 | CA2087143A1 Cenp-b epitope |
| 07/13/1993 | US5227472 3-Methoxy-4-hydroxyphenylethylene glycol |
| 07/13/1993 | US5227469 Platelet aggregation inhibitors from the leech |
| 07/13/1993 | US5227466 Insulin receptor binding site |
| 07/13/1993 | US5227397 Polyamines and polypeptides useful as antagonists of excitatory amino acid neuro-transmitters and/or as blockers of calcium channels |
| 07/13/1993 | US5227368 Endotoxin-induced thrombosis factor which induces procoagulant activity in endothelial cells |
| 07/13/1993 | US5227302 DNA encoding platelet derived endothelial cell growth factor (PD-ECGF) |
| 07/13/1993 | US5227293 Fusion proteins, their preparation and use |
| 07/13/1993 | US5227292 Neurofibromatosis type 1 gene |
| 07/13/1993 | US5227160 Contraceptives, treatment of infertility |
| 07/13/1993 | US5227154 Phosphopeptides for the treatment of dental calculus |
| 07/13/1993 | US5226877 Method and apparatus for preparing fibrinogen adhesive from whole blood |
| 07/13/1993 | CA1320163C Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
| 07/13/1993 | CA1320162C Method for stabilizing heterologous protein expression and vectors for use therein |
| 07/13/1993 | CA1320161C Steroid/thyroid hormone receptor-related gene, which is inappropriately expressed in human heptocellular carcinoma, and which is a retinoic acid receptor |
| 07/13/1993 | CA1320160C Monoclonal antibodies against ifn-omega, processes for preparing them and their use in the purification and detection of ifn-omega |
| 07/10/1993 | CA2086863A1 Novel plant promoter |
| 07/08/1993 | WO1993014110A1 Method for isolating biomolecules with linear polymers |
| 07/08/1993 | WO1993013421A1 Immunochemical detection of in vivo advanced glycosylation endproducts |
| 07/08/1993 | WO1993013417A1 Receptor/oncogene growth factor system in breast cancer |
| 07/08/1993 | WO1993013222A1 Dna structure-specific recognition protein and uses therefor |
| 07/08/1993 | WO1993013218A1 Endothelin-antagonizing peptide |
| 07/08/1993 | WO1993013211A1 Expression and purification of recombinant soluble tissue factor |
| 07/08/1993 | WO1993013210A1 Icams immunoglobulin constant region soluble fusion proteins |
| 07/08/1993 | WO1993013209A1 Expression signal-peptide-free staphylokinases |
| 07/08/1993 | WO1993013208A1 Methods for producing thrombin |
| 07/08/1993 | WO1993013206A1 Stem cell inhibiting proteins |
| 07/08/1993 | WO1993013205A1 Neuroblastoma-associated regulator gene |
| 07/08/1993 | WO1993013204A2 Agent for stimulating animal cell division |
| 07/08/1993 | WO1993013203A1 Hybrid cells producing an antigen characteristic of the hepatitis b virus |
| 07/08/1993 | WO1993013202A1 Immunogenic detoxified mutants of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines |
| 07/08/1993 | WO1993013200A1 A process for the preparation of lipase |
| 07/08/1993 | WO1993013196A2 Method for increasing recombinant protein production |
| 07/08/1993 | WO1993013134A1 Monoclonal antibody to hiv-2 and uses thereof |
| 07/08/1993 | WO1993013132A1 Novel megakaryocyte amplifier |
| 07/08/1993 | WO1993013130A1 Somatostatin receptors |
| 07/08/1993 | WO1993013129A1 Novel rxr-containing heterodimers and method of use |
| 07/08/1993 | WO1993013128A1 Methods of producing analgesia and enhancing opiate analgesia |
| 07/08/1993 | WO1993013127A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus |
| 07/08/1993 | WO1993013126A1 Peptide compounds having therapeutic activity |
| 07/08/1993 | WO1993013125A1 Protein production |
| 07/08/1993 | WO1993013121A1 Gapped 2' modified oligonucleotides |
| 07/08/1993 | WO1993013119A1 Hematopoietic cell specific transcriptional regulatory elements of serglycin and uses thereof |
| 07/08/1993 | WO1993013114A1 COMPOSITIONS AND METHODS FOR MODULATING β-AMYLOID |
| 07/08/1993 | WO1993013089A1 Macrocyclic polyether carboxylic acids |
| 07/08/1993 | WO1993013065A1 Proline derivative |
| 07/08/1993 | WO1993012819A1 Protein- and peptide-metal ion pharmaceutical applications |
| 07/08/1993 | WO1993012815A1 Method for obtaining recombinant surface antigen of hepatitis b, antigen and vaccine based on it |
| 07/08/1993 | WO1993012814A2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 07/08/1993 | WO1993012812A1 A stabilized pharmaceutical formulation comprising growth hormone and histidine |
| 07/08/1993 | WO1993012810A1 Pharmaceutical pentapeptide compositions and methods of use thereof |
| 07/08/1993 | WO1993012807A1 Bone reinforcing factor, and food and drink containing said factor |
| 07/08/1993 | WO1993012805A1 Methods for regulatory lineages of human hematopoietic cells |
| 07/08/1993 | WO1993012803A1 Growth-simulating material, process for preparing the same and therapeutical composition |
| 07/08/1993 | WO1993012781A2 Creatine analogs having antiviral activity |
| 07/08/1993 | WO1993012777A1 Use of polyamines as ionic-channel regulating agents |
| 07/08/1993 | WO1993012756A2 Transfection of lung via aerosolized transgene delivery |
| 07/08/1993 | WO1993012736A1 Mineralized collagen |
| 07/08/1993 | WO1993012667A1 Purification of zein from corn gluten meal |
| 07/08/1993 | WO1993012139A1 A novel molecule which inhibits neuropeptide tyrosine biological function |
| 07/08/1993 | WO1993011158A3 Non-a, non-b peptides |
| 07/08/1993 | DE4143279A1 New DNA sequence encoding staphylokinase - with corresp. proteins used as plasminogen activators in treatment of thrombosis |
| 07/08/1993 | CA2127275A1 Pharmaceutical pentapeptide compositions and methods of use thereof |
| 07/08/1993 | CA2126693A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus |
| 07/08/1993 | CA2126686A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 07/08/1993 | CA2126668A1 Purification of zein from corn gluten meal |
| 07/08/1993 | CA2126451A1 Compositions and methods for modulating .beta.-amyloid |
| 07/08/1993 | CA2126247A1 Monoclonal antibody to hiv-2 and uses thereof |
| 07/08/1993 | CA2126236A1 Peptide compounds having therapeutic activity |
| 07/08/1993 | CA2126212A1 A novel molecule which inhibits neuropeptide tyrosine biological function |
| 07/08/1993 | CA2126209A1 Immunochemical detection of in vivo advanced glycosylation endproducts |
| 07/08/1993 | CA2125853A1 Protein production |
| 07/08/1993 | CA2125563A1 Creatine analogs having antiviral activity |
| 07/08/1993 | CA2117293A1 Neuroblastoma-associated regulator gene |
| 07/08/1993 | CA2104952A1 Endothelin-antagonizing peptide |
| 07/08/1993 | CA2104772A1 Method for isolating biomolecules with linear polymers |
| 07/07/1993 | EP0550400A2 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 07/07/1993 | EP0550296A2 Vascular endothelial cells growth factor |
| 07/07/1993 | EP0550035A2 Composition of stabilized fibroblast growth factor |
| 07/07/1993 | EP0549915A1 New synthetic isohirudines with enhanced stability |
| 07/07/1993 | EP0549742A1 USE OF CANPs-INHIBITORS IN PHARMACEUTICAL PREPARATIONS |